Nevertheless, conformational transformations, revealed after neurotrophin binding with p75NTR and favorable to simultaneous binding of Trk and p75NTR monomers with the same neurotrophin dimer [23], might be a reasonable basis for development of a potentially effective approach to treat the AD-associated cholinergic malfunctioning. The gene discussed is NTRK1; the disease is Alzheimer disease.